Among these genes, high expression of certain genes, such as FLNA and DSTN, is positively correlated with the prognosis of prostate cancer patients, while elevated expression of other genes, including FLNB and INF2, is associated with a negative prognosis (Figure 1D). This evidence concerns the gene FLNA and prostate carcinoma.